Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2026-02-13 00:00:00 ET · period of report 2026-02-11 · accession 0001674236-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-13 | 2026-02-11 | ANIP | CAREY STEPHEN P. | SVP, CFO | F - Tax | $76.25 | -5,503 | 175.4K | -3% | -$419.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-11 | F | D | 5,503 | $76.25 | 175,360 | D | — | — | (F1) Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 16,210 performance stock units, the grant of which was previously reported on April 6, 2023. |